Organizing knowledge to enable personalization of medicine in cancer

Interpretation of the clinical significance of genomic alterations remains the most severe bottleneck preventing the realization of personalized medicine in cancer. We propose a knowledge commons to facilitate collaborative contributions and open discussion of clinical decision-making based on genomic events in cancer.

[1]  References , 1971 .

[2]  S. Antonarakis,et al.  Corrigendum: Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion , 2002, Human mutation.

[3]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[4]  T. Fleming,et al.  Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. , 2001, The New England journal of medicine.

[5]  Patricia L. Harris,et al.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.

[6]  S. Gabriel,et al.  EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.

[7]  T. Hubbard,et al.  A census of human cancer genes , 2004, Nature Reviews Cancer.

[8]  R. Durbin,et al.  The Sequence Ontology: a tool for the unification of genome annotations , 2005, Genome Biology.

[9]  Amy Bruckman,et al.  Becoming Wikipedian: transformation of participation in a collaborative online encyclopedia , 2005, GROUP.

[10]  J. Giles.  Internet encyclopaedias go head to head , 2005, Nature.

[11]  Markus Krötzsch,et al.  Semantic MediaWiki , 2006, Foundations for the Web of Information and Services.

[12]  Kei-Hoi Cheung,et al.  Advancing translational research with the Semantic Web , 2007, BMC Bioinformatics.

[13]  Winston A Hide,et al.  Big data: The future of biocuration , 2008, Nature.

[14]  Andrew I. Su,et al.  The Gene Wiki: community intelligence applied to human gene annotation , 2009, Nucleic Acids Res..

[15]  Cathy H. Wu,et al.  Community annotation in biology , 2010, Biology Direct.

[16]  Gary D Bader,et al.  International network of cancer genome projects , 2010, Nature.

[17]  Steven J. M. Jones,et al.  Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors , 2010, Genome Biology.

[18]  Lee T. Sam,et al.  Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study , 2011, Science Translational Medicine.

[19]  Rob W.W. Hooft,et al.  The value of data , 2011, Nature Genetics.

[20]  Brent S. Pedersen,et al.  BioStar: An Online Question & Answer Resource for the Bioinformatics Community , 2011, PLoS Comput. Biol..

[21]  Robert D. Finn,et al.  Rfam: Wikipedia, clans and the “decimal” release , 2010, Nucleic Acids Res..

[22]  Ken Chen,et al.  Use of whole-genome sequencing to diagnose a cryptic fusion oncogene. , 2011, JAMA.

[23]  Li Ding,et al.  Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML. , 2011, JAMA.

[24]  Luca de Alfaro,et al.  The Gene Wiki in 2011: community intelligence applied to human gene annotation , 2011, Nucleic Acids Res..

[25]  Jennifer Preece,et al.  Supporting content curation communities: The case of the Encyclopedia of Life , 2012, J. Assoc. Inf. Sci. Technol..

[26]  Robert Schmieder,et al.  SEQanswers: an open access community for collaboratively decoding genomes , 2012, Bioinform..

[27]  Gang Feng,et al.  Disease Ontology: a backbone for disease semantic integration , 2011, Nucleic Acids Res..

[28]  Steven J. Marygold,et al.  Directly e-mailing authors of newly published papers encourages community curation , 2012, Database J. Biol. Databases Curation.

[29]  Kimberly Van Auken,et al.  WormBase 2012: more genomes, more data, new website , 2011, Nucleic Acids Res..

[30]  R. Wilson,et al.  The Next-Generation Sequencing Revolution and Its Impact on Genomics , 2013, Cell.

[31]  F. Gnad,et al.  Assessment of computational methods for predicting the effects of missense mutations in human cancers , 2013, BMC Genomics.

[32]  Joshua F. McMichael,et al.  DGIdb - Mining the druggable genome , 2013, Nature Methods.

[33]  Stephen H Friend,et al.  Metcalfe's law and the biology information commons , 2013, Nature Biotechnology.

[34]  E. V. Van Allen,et al.  Clinical analysis and interpretation of cancer genome data. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  William Pao,et al.  DNA-Mutation Inventory to Refine and Enhance Cancer Treatment (DIRECT): A Catalog of Clinically Relevant Cancer Mutations to Enable Genome-Directed Anticancer Therapy , 2013, Clinical Cancer Research.

[36]  James Cheney,et al.  The W3C PROV family of specifications for modelling provenance metadata , 2013, EDBT '13.

[37]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[38]  P. Stenson,et al.  The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine , 2013, Human Genetics.

[39]  Rodrigo Dienstmann,et al.  Standardized decision support in next generation sequencing reports of somatic cancer variants , 2014, Molecular oncology.

[40]  F. Mitelman,et al.  Mitelman database of chromosome aberrations and gene fusions in cancer , 2014 .

[41]  Michael R. Speicher,et al.  A survey of tools for variant analysis of next-generation genome sequencing data , 2013, Briefings Bioinform..

[42]  M. Vihinen.  Variation Ontology for annotation of variation effects and mechanisms , 2014, Genome research.

[43]  Deanna M. Church,et al.  ClinVar: public archive of relationships among sequence variation and human phenotype , 2013, Nucleic Acids Res..

[44]  Dennis C. Friedrich,et al.  Whole-exome sequencing and clinical interpretation of formalin-fixed , paraffin-embedded tumor samples to guide precision cancer medicine , 2014 .

[45]  O. Griffith,et al.  Mitelman Database (Chromosome Aberrations and Gene Fusions in Cancer) , 2014 .

[46]  K. Yamamoto,et al.  GLOBAL ALLIANCE FOR GENOMICS AND HEALTH , 2015 .